References
1. International Diabetes Federation. Diabetes Atlas. 9th ed; 2019.
2. The Federal register of patients with diabetes. Professional All-Russian Resource on Diabetes Nosology under the auspices of Endocrinology Research Center/http://diaregistry.ru/content/o-proekte.html#content Verified on May 28, 2018. (in Russian)
3. Algorithms of specialized medical care for diabetes mellitus patients. Edited by I.I. Dedov, M.V. Shestakova. 9th ed. Moscow; 2019. (in Russian)
4. Dedov I.I., Shestakova M.V., Galstyan G.R. Prevalence of type 2 diabetes mellitus in adult Russian population (NATION study). Sakharni Diabet [Diabetes Mellitus]. 2016; 19 (2): 104-12. (in Russian)
5. Ametov A.S. Type 2 diabetes. Problems and solutions. Moscow: GEOTAR-Media, 2017; 6: 125-44. (in Russian)
6. Starodubova A.V., Chervyakova Yu.V., Kopelev A.A., Alieva A.M. Possibilities of medical correction of metabolic disorders and prevention of diabetes mellitus in disorders of carbohydrate metabolism. Lechebnoe delo [Medical Business]. 2015; (3): 59-65. (in Russian)
7. Barry E. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions. BMJ. 2017; 356: i6538.
8. Diabetes Prevention Program Research Group. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care. 2012; 35 (4): 723-30.
9. Аmetov А.S., Кrivosheyeva А.А. Prevention of type 2 diabetes mellitus. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2017; (4): 14-25. (in Russian)
10. Diabetes Prevention Program Research Group. Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2012; 35 (4): 731-7.
11. Chazova I.E., Mychka V.B., Belenkov Yu.N. The main results of the Russian program APRIL (the effectiveness of acarbose in patients with impaired glucose tolerance and hypertension). Consilium medicum. 2005; (2): 18-22. (in Russian)
12. Madsen K.S., Chi Y., Metzendorf M.I., Richter B., Hemmingsen B. Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus. Cochrane Dat Syst Rev. 2019: (12): CD 008558.
13. Demidova I.Yu., Boeva V.V. Early Diagnosis and treatment of initial stages of carbohydrate metabolism disorders. Vestnik Rossiyskogo gosudarstvennogo meditsinskogo universiteta [Bulletin of Russian State Medical University]. 2013; (1): 9-13. (in Russian)
14. 3. Prevention or delay of type 2 diabetes: Standards of medical care in diabetes-2019. Diabetes Care. 2019; 42 (Suppl. 1): S 29-33.
15. Аmetov А.S, Кrivosheyeva А.А. Prospects of early pharmacological intervention at the stage of prediabetes. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2018; 7 (3): 75-87.
16. Naidoo P., et al. Effect of sitagliptin and metformin on prediabetes progression to type 2 diabetes - A randomized, double-blind, doublearm, multicenter clinical trial: Protocol for the Sitagliptin and Metformin in PreDiabetes (SiMePreD) Study. JMIR Res Protoc. 2016; 5 (3): e145.
17. International Diabetes Federation. Clinical practice recommendations for managing type 2 diabetes in primary care. Brussels, 2017
18. The State Register of Medicines. Registration certificate. URL: http://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid = 7ff34cc5-7fbe-4cd4-9546-8dbdf1941b3c&t= (date of access: 12.08.2019) (in Russian)
19. The State Register of Medicines. Registration certificate. URL: http://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=a7f442c7-6246-412c-869f-db0dbb28623b&t= (date of access: 12.08.2019) (in Russian)
20. Decree of the Government of the Russian Federation of May 10, 2007. "On the federal target program "Prevention and control of socially significant diseases (2007-2012)" No. 280.
21. The results of the implementation of the "Diabetes mellitus" subprogram of the Federal target program "Prevention and Control of Socially Significant Diseases 2007-2012". Edited by Dedov I.I., Shestakova M.V. Sakharni Diabet [Diabetes Mellitus]. 2013; Special Edition 2S: 2-18.
22. Order of the Ministry of Health of Russian Federation оf December 3 2012 No. 1006н.
23. Chiasson J.-L., Josse R.G., Gomis R., Hanefeld M., Karasik A., Laakso M., et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002; 359 (9323): 2072-7.
24. Holman R., North B., Tunbridge F. Possible prevention of type 2 diabetes with acarbose or metformin. Diabetes. 2000; 49 (Suppl 1): A111.
25. Wenying Y., Lixiang L., Jinwu Q. The preventive effect of acarbose and metformin on the progression to diabetes mellitus in the IGT population: 3-year multicenter prospective study. Chin J Endocrin Metab. 2001; 17.